Condition

Endocrine Therapy

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 12 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12
Recruiting6
Common interventions17
Lead sponsors shown11
Advertisement

Clinical trials

12 shown
Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.NCT07443774 · 2026-05-26
RECRUITING
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)NCT07190443 · 2025-02-07
RECRUITING
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled TrialNCT06642948 · 2024-10-20
RECRUITING
The Benefits of Continued Use of Ovarian Function Suppression After 5 YearsNCT06050109 · 2023-09-01
RECRUITING
Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.NCT06033287 · 2023-01-01
RECRUITING
Assessment of Brain Cognitive Impairment in Breast CancerNCT05305092 · 2022-05-31
RECRUITING
Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)NCT07840534 · 2026-10-01
NOT_YET_RECRUITING
Symptom Monitoring Using Patient-Report to Improve Medication UseNCT06765707 · 2025-06-23
ENROLLING_BY_INVITATION
Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study ProtocolNCT06754293 · 2024-12-01
ACTIVE_NOT_RECRUITING
Effect of Yoga Program on Quality of Life in Women With Breast Cancer Receiving Endocrine TherapyNCT06605261 · 2024-10-29
ACTIVE_NOT_RECRUITING
Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase InhibitorsNCT05628077 · 2022-12-30
UNKNOWN
Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast CancerNCT04389424 · 2017-09-01
UNKNOWN

Common interventions

Trial status mix

RECRUITING6
ACTIVE_NOT_RECRUITING2
UNKNOWN2
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1

Phase mix

NA5
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.